Topical cannabinoid enhances topical morphine antinociception
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Opioids and cannabinoids produce antinociception through both spinal and supraspinal action. Both opioids and cannabinoids also have important peripheral action. Many previous studies indicate that systemically administered cannabinoids enhance antinociceptive properties of opioids. Experiments were conducted to test the hypothesis that topical cannabinoids would enhance the topical antinociceptive effects of morphine. Antinociception was measured in the radiant tail-flick test after immersion of the tail of mice into a solution of dimethyl sulfoxide (DMSO) containing WIN 55, 212-2, a cannabinoid agonist and morphine, an opioid agonist. Morphine and WIN 55, 212-2 produce time dependent topical analgesic effects limited to the portion of the tail exposed to drugs. WIN 55, 212-2 had a potency lower than that of morphine. The topical antinociceptive effects of WIN 55, 212-2 were blocked by systemic pretreatment of cannabinoid CB1 receptor selective antagonist, AM 251. This suggests that topical antinociceptive effects of WIN 55, 212-2 involve CB1 receptors. Combination of topical WIN 55, 212-2 with topical morphine yielded significantly greater analgesic effects than that of topical morphine alone. The ability of the CB1 receptor antagonist AM 251 to antagonize the enhancement of antinociception of morphine by WIN 55, 212-2 indicates that WIN 55, 212-2 acts through a CB1 receptor to enhance the potency of topical morphine. Additionally, spinally administered ineffective doses of WIN 55, 212-2 potentiated the antinociceptive effects of topical morphine. These results demonstrate an antinociceptive interaction between topical opioids with topical, and spinal cannabinoids. These observations are significant in using of topical combination of cannabinoid and morphine in the management of pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722 · cited 1×
“It has been reported that topical antinociceptive effects of morphine were mediated through mu receptors located on the terminals of sensory neurons from the dorsal root ganglia (Kolesnikov et al., 1996; Matthes et al., 1996; Ono et al., 2002).”
BackgroundGatley, S. J., Gifford, A. N., Volkow, N. D., Lan, R., & Makriyannis, A. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00279-8 · Cited by 252 · cited 1×
“Morphine hydrochloride was obtained from Sandoz (Switzerland) and R-(þ )-WIN 55, 212-2, a mixed CB1/CB2 receptor agonist was obtained from Sigma-RBI (St Louis, USA) and AM 251, a 300-fold selective CB1 receptor antagonist (Gatley et al., 1996) was obtained from Tocris (Ellisville, USA).”
MethodAntinociceptive Synergy between Δ9-Tetrahydrocannabinol and Opioids after Oral Administration
Cichewicz, D. L., & McCarthy, E. A. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045575 · Cited by 154 · cited 4×
“Clearly, the low doses of drugs together could produce high magnitude antinociceptive effect would be important in pain treatment (Cichewicz and McCarthy, 2003).”
BackgroundInfluentialThe Enhancement of Morphine Antinociception in Mice by Î9-Tetrahydrocannabinol
Smith, F. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00012-4 · Cited by 146 · cited 3×
“…that systemically, spinally and supraspinally administered cannabinoids enhance antinociceptive properties of opioids (Welch and Stevens, 1992; Welch et al., 1995; Pugh et al., 1996; Smith et al., 1998; Cichewicz et al., 1999; Welch and Eads, 1999; Massi et al., 2001; Cichewicz and McCarthy, 2003).”
BackgroundPugh, G., Smith, P. B., Dombrowski, D. S., & Welch, S. P. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21168-5 · Cited by 123 · cited 2×
“…that systemically, spinally and supraspinally administered cannabinoids enhance antinociceptive properties of opioids (Welch and Stevens, 1992; Welch et al., 1995; Pugh et al., 1996; Smith et al., 1998; Cichewicz et al., 1999; Welch and Eads, 1999; Massi et al., 2001; Cichewicz and McCarthy, 2003).”
Background
Cited by
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Pertwee, R. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00048.x · Cited by 436
“Keywords: cannabis; D9-tetrahydrocannabinol; CB1 receptors; CB2 receptors; cannabinoid receptor agonism; clinical applications; clinical strategies; blood-brain barrier; synergistic interactions; endocannabinoid system Abbreviations: 8-OH-DPAT, 8-hydroxy-2-(di-n-propylamino) tetralin hydrobromide; ACEA, arachidonyl-2′…”
BackgroundInfluentialPertwee, R. G. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0381 · Cited by 347
Ständer, S., Schmelz, M., Metze, D., Luger, T., & Rukwied, R. (2005) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2005.01.007 · Cited by 298
Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis
Nielsen, S., Sabioni, P., Trigo, J. M., Ware, M. A., Betz-Stablein, B. D., Murnion, B., Lintzeris, N., Khor, K. E., Farrell, M., Smith, A., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.51 · Cited by 265
The analgesic potential of cannabinoids.
Elikottil, M., Gupta, M., & Gupta, P. (2018) · Journal of Opioid Management · doi:10.5055/jom.2009.0034 · Cited by 141
“Synergistic effect with an opioid-cannabinoid combination has been shown in other studies as well, using systemic [54, 55, 52, 56, 57] or topical agonists [58].”
Background
Metadata
- Authors
- Yesilyurt, O., Dogrul, A., Gul, H., Seyrek, M., Kusmez, O., Ozkan, Y., & Yildiz, O.
- Venue
- Pain
- Published
- 2003-09
- Volume
- 105
- Issue
- 1
- Pages
- 303-308
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2091491637
- Cited by
- 96
- References
- 5
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Topical cannabinoid enhances topical morphine antinociception. https://app.cochat.ai/papers/10.1016/s0304-3959(03)00245-8
- The paper
- Yesilyurt, O., Dogrul, A., Gul, H., Seyrek, M., Kusmez, O., Ozkan, Y., & Yildiz, O. (2003). Topical cannabinoid enhances topical morphine antinociception. Pain. https://doi.org/10.1016/s0304-3959(03)00245-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.